TT International’s Dr. Reddy's Laboratories RDY Stock Holding History

TT International’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-74,400	Closed	-$690K	–	50
2016 Q3	$690K	Sell	74,400 -150,480	-67%	-$1.44M	0.19%	45
2016 Q2	$2.3M	Buy	224,880 +5,835	+3%	+$53.5K	0.78%	35
2016 Q1	$1.98M	Buy	219,045 +171,285	+359%	+$1.53M	0.77%	34
2015 Q4	$442K	Sell	47,760 -14,625	-23%	-$160K	0.17%	38
2015 Q3	$797K	Buy	+62,385	New	+$775K	0.41%	36

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

TT International's RDY Position: Q4 2016 in Review

TT International sold out of Dr. Reddy's Laboratories (RDY) in Q4 2016, closing a stake of 74,400 shares — an estimated $690K sold.

TT International first reported a position in RDY in Q3 2015 and held it in 5 quarters. The position peaked at $2.3M in Q2 2016. 164 funds tracked by Wall St. Rank hold RDY as of Q4 2016.

TT International reported no remaining Dr. Reddy's Laboratories position as of Q4 2016 after selling out during the quarter.
TT International sold 74,400 Dr. Reddy's Laboratories shares in Q4 2016, an estimated $690K.
TT International first reported a position in Dr. Reddy's Laboratories in Q3 2015 and held it in 5 quarters.
TT International's Dr. Reddy's Laboratories position peaked at $2.3M in Q2 2016.
164 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2016.

Based on TT International's 13F filing for Q4 2016, filed 24 Jan 2017.